Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ReNeuron's Cell Therapies Attract Fosun Pharma, A Leading Regenerative Medicines Developer

Apr 10 2019

• By John Davis

Shanghai — ReNeuron seals deal for China • Source: Shutterstock

Related Content

China's Draft Cell Therapy Guidelines Draws Concern From Industry

Apr 09 2019

Kite Flies CAR-T Into Asia With Daiichi Sankyo, Fosun Deals

Jan 11 2017

Related Companies

ReNeuron Group plc

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Kite Pharma, Inc.

Gilead Sciences, Inc.

Additional Topics

China Asia Pacific Deals Regenerative Medicine Commercial Rare Diseases Neurology Ophthalmic BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window